ISSUER TOIndenture • August 3rd, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2001 Company Industry Jurisdiction
LEASE -----Cor Therapeutics Inc / De • October 31st, 2001 • Pharmaceutical preparations
Company FiledOctober 31st, 2001 Industry
EXHIBIT 99.2 AMENDMENT TO RIGHTS AGREEMENT BETWEEN COR THERAPEUTICS, INC. AND MELLON INVESTOR SERVICES LLC THIS AMENDMENT TO RIGHTS AGREEMENT (the "Amendment") is made this 5th day of December, 2001, by and between COR THERAPEUTICS, INC., a Delaware...Rights Agreement • December 7th, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 7th, 2001 Company Industry Jurisdiction
EXHIBIT 10.1 COR Therapeutics, Inc. 4.50% Convertible Senior Notes due June 15, 2006 Purchase Agreement ------------------Purchase Agreement • August 3rd, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2001 Company Industry Jurisdiction
EXHIBIT 10.2 COR Therapeutics, Inc. 4.50% Convertible Senior Notes due June 15, 2006 Registration Rights Agreement -----------------------------Cor Therapeutics Inc / De • August 3rd, 2001 • Pharmaceutical preparations • New York
Company FiledAugust 3rd, 2001 Industry Jurisdiction
CONFIDENTIAL TREATMENT REQUESTED = [*] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....Agreement • November 13th, 1998 • Cor Therapeutics Inc / De • Pharmaceutical preparations • England
Contract Type FiledNovember 13th, 1998 Company Industry Jurisdiction
Exhibit 10.1 COR THERAPEUTICS, INC. 5.00% CONVERTIBLE SUBORDINATED NOTES DUE MARCH 1, 2007 PURCHASE AGREEMENTPurchase Agreement • May 10th, 2000 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2000 Company Industry Jurisdiction
AMENDMENT TO COLLABORATION AGREEMENT AMONG COR THERAPEUTICS, INC., SCHERING CORPORATION AND SCHERING-PLOUGH, LTD. DATED APRIL 10, 1995Collaboration Agreement • March 25th, 1999 • Cor Therapeutics Inc / De • Pharmaceutical preparations
Contract Type FiledMarch 25th, 1999 Company Industry
EXHIBIT 10.2 COR THERAPEUTICS, INC. 5.00% CONVERTIBLE SUBORDINATED NOTES DUE MARCH 1, 2007 REGISTRATION RIGHTS AGREEMENTCor Therapeutics Inc / De • May 10th, 2000 • Pharmaceutical preparations • New York
Company FiledMay 10th, 2000 Industry Jurisdiction
1 EXHIBIT 10.26 SECOND AMENDMENT TO THE LICENSE AND SUPPLY AGREEMENT BETWEEN COR THERAPEUTICS AND SOLVAY This Amendment is entered into effective as of the 1st day of June, 1995 between COR THERAPEUTICS, INC. ("COR"), a Delaware corporation, with its...License and Supply Agreement • November 13th, 1998 • Cor Therapeutics Inc / De • Pharmaceutical preparations
Contract Type FiledNovember 13th, 1998 Company Industry
AND-Promotion Agreement • May 9th, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • California
Contract Type FiledMay 9th, 2001 Company Industry Jurisdiction
AMENDMENT NO. 1 TO THE LONG TERM SUPPLY AGREEMENT BETWEEN COR THERAPEUTICS, INC. AND SOLVAY, S. A. THIS AMENDMENT NO. 1 to the Long Term Supply Agreement (the "Amendment") is entered into between COR Therapeutics, Inc. ("COR"), a Delaware corporation,...Term Supply Agreement • November 13th, 1998 • Cor Therapeutics Inc / De • Pharmaceutical preparations • England
Contract Type FiledNovember 13th, 1998 Company Industry Jurisdiction
CONFIDENTIAL TREATMENT REQUESTED = [*] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....Long Term Supply Agreement • November 13th, 1998 • Cor Therapeutics Inc / De • Pharmaceutical preparations • England
Contract Type FiledNovember 13th, 1998 Company Industry Jurisdiction
July 27, 2000 Mr. Vaughn M. Kailian, CEO COR Therapeutics, Inc. 256 East Grand Avenue South San Francisco, California 94080 Dear Vaughn: This is with regard to the Collaboration Agreement, dated April 10, 1995, by and among COR Therapeutics, Inc....Cor Therapeutics Inc / De • November 8th, 2000 • Pharmaceutical preparations
Company FiledNovember 8th, 2000 Industry
COR COR THERAPEUTICS, INC ----------------------------------------------------- ---------------------------Qualified Stock Option Agreement • October 31st, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations
Contract Type FiledOctober 31st, 2001 Company Industry
AMENDMENT NO. 5 TO COLLABORATION AGREEMENTCollaboration Agreement • March 31st, 1997 • Cor Therapeutics Inc / De • Pharmaceutical preparations
Contract Type FiledMarch 31st, 1997 Company Industry
COR COR Therapeutics, Inc. ---------------------------------------------------- ----------------------------Incentive Plan Stock Option Agreement • October 31st, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations
Contract Type FiledOctober 31st, 2001 Company Industry
SECOND AMENDMENT TO COLLABORATION AGREEMENT AMONG COR THERAPEUTICS, INC., SCHERING CORPORATION AND SCHERING-PLOUGH, LTD. DATED APRIL 10, 1995Collaboration Agreement • March 30th, 2000 • Cor Therapeutics Inc / De • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2000 Company Industry
AMENDMENT NO.1The Agreement • March 31st, 1997 • Cor Therapeutics Inc / De • Pharmaceutical preparations
Contract Type FiledMarch 31st, 1997 Company Industry
August 31, 2000 Mr. Vaughn M. Kailian, CEO COR Therapeutics, Inc. 256 East Grand Avenue South San Francisco, California 94080 Dear Vaughn: This is with regard to the Collaboration Agreement, dated April 10, 1995, by and among COR Therapeutics, Inc....Cor Therapeutics Inc / De • November 8th, 2000 • Pharmaceutical preparations
Company FiledNovember 8th, 2000 Industry
EXHIBIT 99.1 AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • December 7th, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 7th, 2001 Company Industry Jurisdiction